Definium Therapeutics (DFTX) Shares Issued (2019 - 2026)
Definium Therapeutics (DFTX) reported Shares Issued of $1.2 million for Q1 2026, up 106.56% year-over-year from $579000.0 in Q1 2025, and up 219.12% on a QoQ basis from -$1.0 million in Q4 2025.
Definium Therapeutics (DFTX) has 7 years of Shares Issued data on file, last reported at $1.2 million in Q1 2026.
- Quarterly Shares Issued rose 106.56% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $617000.0 (up 252.35% YoY) and the FY2024 annual result came in at $716000.0, up 1361.22% from the prior year.
- Shares Issued improved to $1.2 million in Q1 2026 per DFTX's latest filing, from -$1.0 million in the prior quarter.
- Across five years, Shares Issued topped out at $27.5 million in Q3 2022 and bottomed at -$1.0 million in Q4 2025.
- The 5-year median for Shares Issued is $583000.0 (2023), against an average of $2.0 million.
- Peak annual rise in Shares Issued reached 5302.75% in 2022, while the deepest fall reached 7071.43% in 2022.
- Tracing DFTX's Shares Issued over 5 years: stood at -$502000.0 in 2022, then jumped by 109.76% to $49000.0 in 2023, then surged by 1361.22% to $716000.0 in 2024, then tumbled by 240.22% to -$1.0 million in 2025, then soared by 219.12% to $1.2 million in 2026.
- Per Business Quant, the three latest DFTX Shares Issued figures stand at $1.2 million (Q1 2026), -$1.0 million (Q4 2025), and $670000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Definium Therapeutics | 2.42 Bn | 2.06 Bn | - | 1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | -1.00 Mn |
| Dec 31, 2025 | -1.00 Mn |
| Sep 30, 2025 | 670,000.00 |
| Sep 30, 2025 | 670,000.00 |
| Jun 30, 2025 | -245,000.00 |
| Jun 30, 2025 | -245,000.00 |
| Mar 31, 2025 | 579,000.00 |
| Mar 31, 2025 | 579,000.00 |
| Dec 31, 2024 | 716,000.00 |
| Dec 31, 2024 | 716,000.00 |
| Sep 30, 2024 | -984,000.00 |
| Sep 30, 2024 | -984,000.00 |
| Jun 30, 2024 | -716,000.00 |
| Jun 30, 2024 | -716,000.00 |
| Mar 31, 2024 | 1.70 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Dec 31, 2023 | 49,000.00 |
| Dec 31, 2023 | 49,000.00 |
| Sep 30, 2023 | 3.10 Mn |
| Sep 30, 2023 | 3.10 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Mar 31, 2023 | 583,000.00 |
| Mar 31, 2023 | 583,000.00 |
| Dec 31, 2022 | -502,000.00 |
| Dec 31, 2022 | -502,000.00 |
| Sep 30, 2022 | 27.50 Mn |
| Sep 30, 2022 | 27.50 Mn |
| Jun 30, 2022 | 585,000.00 |
| Jun 30, 2022 | 585,000.00 |
| Mar 31, 2022 | 123,000.00 |
| Mar 31, 2022 | 123,000.00 |
| Dec 31, 2021 | -7,000.00 |
| Dec 31, 2021 | -7,000.00 |
| Sep 30, 2021 | 509,000.00 |
| Sep 30, 2021 | 509,000.00 |
| Jun 30, 2021 | -71.44 Mn |
| Jun 30, 2021 | -71.44 Mn |
| Mar 31, 2021 | 82.11 Mn |
| Mar 31, 2021 | 82.11 Mn |
| Dec 31, 2019 | 9.90 Mn |
| Dec 31, 2019 | 9.90 Mn |